IDEX Biometrics ASA
IDXAF
$0.20
$0.10100.00%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -78.96% | -72.04% | -95.05% | -93.89% | -73.68% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -78.96% | -72.04% | -95.05% | -93.89% | -73.68% |
| Cost of Revenue | -75.54% | -63.71% | 6.27% | -96.18% | -79.65% |
| Gross Profit | -84.21% | -86.67% | -84.15% | -86.18% | -52.20% |
| SG&A Expenses | -73.17% | -71.77% | -46.27% | -48.16% | -36.21% |
| Depreciation & Amortization | -87.27% | -63.87% | 179.17% | -195.88% | 172.95% |
| Other Operating Expenses | -7.78% | -20.81% | 9.43% | -44.51% | -24.33% |
| Total Operating Expenses | -50.85% | -49.19% | 2.64% | -46.74% | -27.98% |
| Operating Income | 49.04% | 47.77% | -11.58% | 40.12% | 18.91% |
| Income Before Tax | 68.31% | 23.58% | 21.64% | 119.33% | 10.79% |
| Income Tax Expenses | -2,250.00% | -- | -913.33% | -- | 106.67% |
| Earnings from Continuing Operations | 68.96% | 23.54% | 24.36% | 119.35% | 10.40% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 68.96% | 23.54% | 24.36% | 119.35% | 10.40% |
| EBIT | 49.04% | 47.77% | -11.58% | 40.12% | 18.91% |
| EBITDA | 40.41% | 46.58% | -12.71% | 40.08% | 30.01% |
| EPS Basic | 96.97% | 74.30% | 60.01% | 116.46% | 20.57% |
| Normalized Basic EPS | 96.91% | 98.93% | 58.57% | 94.18% | 20.91% |
| EPS Diluted | 96.94% | 75.09% | 60.01% | 114.43% | 23.67% |
| Normalized Diluted EPS | 96.91% | 98.93% | 58.40% | 94.16% | 20.75% |
| Average Basic Shares Outstanding | 924.96% | 197.45% | 89.17% | 17.54% | 12.81% |
| Average Diluted Shares Outstanding | 924.96% | 197.45% | 88.36% | 17.09% | 12.57% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |